Company / Tangible Book Value per Share
Kiniksa Pharmaceuticals International, plc Tangible Book Value per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$7.89
FY2025
5-year range
$4.17 / $7.89
FY2021-FY2025
Trend
+26.8%
vs FY2024
Sector context
#65 of 209
Health Care
What the data says
At $7.89, Kiniksa Pharmaceuticals International, plc's tangible book value per share ranks #65 of 209 in the Health Care sector. Tangible Book Value per Share returned to growth in FY2025 after 2 years of decline, reaching $7.89.
Based on SEC 10-K filings.
7.89 in FY2025 with a 5-year CAGR of +9.4%.
Improved from $6.40 to $7.89 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +7.2%
- 5-Year CAGR
- +9.4%
- 10-Year CAGR
- -
Sector benchmark
#65 of 209 in Health CareTop 31% of 209This company $7.89 Sector average $119.74
▼
-93.4% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share increased 26.8% year-over-year.
- Ranks #65 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2018.
- Lowest tangible book value per share in the period was in FY2017.
Company context
Key Data Points
- Negative profit margin: -10.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.89 | +26.8% |
| FY2024 | $6.23 | -2.7% |
| FY2023 | $6.40 | -0.1% |
| FY2022 | $6.41 | +53.6% |
| FY2021 | $4.17 | -17.3% |
| FY2020 | $5.04 | +20.9% |
| FY2019 | $4.17 | -55.9% |
| FY2018 | $9.45 | +119.1% |
| FY2017 | -$49.57 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026